Black Diamond Therapeutics
BDTX
BDTX
80 hedge funds and large institutions have $968M invested in Black Diamond Therapeutics in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.34% more ownership
Funds ownership: 62.09% → 64.43% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
80
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$9.8M | |
| 2 | +$7.45M | |
| 3 | +$6.8M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$6.53M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.36M |
Top Sellers
| 1 | -$6M | |
| 2 | -$5.52M | |
| 3 | -$3.75M | |
| 4 |
Goldman Sachs
New York
|
-$2.69M |
| 5 |
JP Morgan Chase
New York
|
-$982K |